Immediate and Delayed Procedural Stroke or Death in Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis

Background and Purpose— Stenting for symptomatic carotid stenosis (carotid artery stenting [CAS]) carries a higher risk of procedural stroke or death than carotid endarterectomy (CEA). It is unclear whether this extra risk is present both on the day of procedure and within 1 to 30 days thereafter and whether clinical risk factors differ between these periods. Methods— We analyzed the risk of stroke or death occurring on the day of procedure (immediate procedural events) and within 1 to 30 days thereafter (delayed procedural events) in 4597 individual patients with symptomatic carotid stenosis who underwent CAS (n=2326) or CEA (n=2271) in 4 randomized trials. Results— Compared with CEA, patients treated with CAS were at greater risk for immediate procedural events (110 versus 42; 4.7% versus 1.9%; odds ratio, 2.6; 95% CI, 1.9–3.8) but not for delayed procedural events (59 versus 46; 2.5% versus 2.0%; odds ratio, 1.3; 95% CI, 0.9–1.9; interaction P=0.006). In patients treated with CAS, age increased the risk for both immediate and delayed events while qualifying event severity only increased the risk of delayed events. In patients treated with CEA, we found no risk factors for immediate events while a higher level of disability at baseline and known history of hypertension were associated with delayed procedural events. Conclusions— The increased procedural stroke or death risk associated with CAS compared with CEA was caused by an excess of events occurring on the day of procedure. This finding demonstrates the need to enhance the procedural safety of CAS by technical improvements of the procedure and increased operator skill. Higher age increased the risk for both immediate and delayed procedural events in CAS, mechanisms of which remain to be elucidated. Clinical Trial Registration— URL: https://clinicaltrials.gov. Unique identifier: NCT00190398. URL: http://www.isrctn.com. Unique identifier: ISRCTN57874028. URL: http://www.isrctn.com. Unique identifier: ISRCTN25337470. URL: https://clinicaltrials.gov. Unique identifier: NCT00004732.

[1]  A. Algra,et al.  Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials , 2016, The Lancet.

[2]  S. Macdonald,et al.  Predictors of Stroke, Myocardial Infarction or Death within 30 Days of Carotid Artery Stenting: Results from the International Carotid Stenting Study , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  V. Howard,et al.  Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. , 2016, The New England journal of medicine.

[4]  S. Macdonald,et al.  Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. , 2015, Journal of vascular surgery.

[5]  P. Dorman,et al.  Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial , 2015, The Lancet.

[6]  I. Gonçalves,et al.  Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients. , 2014, Atherosclerosis.

[7]  D. Leys,et al.  Long-Term Follow-Up Study of Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis Trial , 2014, Stroke.

[8]  M. Mokin,et al.  Proximal versus distal protection during carotid artery stenting: analysis of the two treatment approaches and associated clinical outcomes. , 2014, World neurosurgery.

[9]  J. Schofer,et al.  The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial. , 2012, Journal of the American College of Cardiology.

[10]  P. Rothwell,et al.  Histological Features of Symptomatic Carotid Plaques in Relation to Age and Smoking: The Oxford Plaque Study , 2010, Stroke.

[11]  A. Algra,et al.  Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data , 2010, The Lancet.

[12]  D. Scheinert,et al.  Safety and effectiveness of the INVATEC MO.MA® proximal cerebral protection device during carotid artery stenting: Results from the ARMOUR pivotal trial , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  H. Jäger,et al.  New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS) , 2010, Lancet Neurology.

[14]  A. Bozzao,et al.  Cervical access for filter-protected carotid artery stenting: a useful tool to reduce cerebral embolisation. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[15]  V. Howard,et al.  Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) , 2010, International journal of stroke : official journal of the International Stroke Society.

[16]  S. Macdonald,et al.  Filter-Protected versus Unprotected Carotid Artery Stenting: A Randomised Trial , 2010, Cerebrovascular Diseases.

[17]  W. Hacke,et al.  Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial , 2008, The Lancet Neurology.

[18]  E. Kanal,et al.  A randomized trial of carotid artery stenting with and without cerebral protection. , 2008, Journal of vascular surgery.

[19]  P. Faries,et al.  The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. , 2007, Journal of vascular surgery.

[20]  R. Dayal,et al.  Analysis of Anatomic Factors and Age in Patients Undergoing Carotid Angioplasty and Stenting , 2005, Annals of vascular surgery.

[21]  F. Meyer,et al.  Carotid revascularization for prevention of stroke: carotid endarterectomy and carotid artery stenting. , 2004, Mayo Clinic proceedings.

[22]  E. EVA-3S Investigators.  Endarterectomy vs. Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) Trial , 2004, Cerebrovascular Diseases.

[23]  M. Brown,et al.  International Carotid Stenting Study: Protocol for a Randomised Clinical Trial Comparing Carotid Stenting with Endarterectomy in Symptomatic Carotid Artery Stenosis , 2004, Cerebrovascular Diseases.

[24]  W. Hacke,et al.  The Stent-Supported Percutaneous Angioplasty of the Carotid Artery vs. Endarterectomy Trial , 2004, Cerebrovascular Diseases.

[25]  W. Hacke,et al.  Carotid Artery Stenting:The Need for Randomised Trials , 2004, Cerebrovascular Diseases.

[26]  M. Eliasziw,et al.  Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery , 2004, The Lancet.

[27]  G. Chatellier,et al.  Carotid Angioplasty and Stenting With and Without Cerebral Protection: Clinical Alert From the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) Trial , 2004, Stroke.

[28]  E. Investigators.  Endarterectomy vs. Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) Trial. , 2004 .

[29]  E. Investigators.  Carotid Angioplasty and Stenting With and Without Cerebral Protection: Clinical Alert From the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) Trial , 2004 .

[30]  H. Barnett,et al.  Symptomatic carotid artery stenosis: a solvable problem. North American Symptomatic carotid Endarterectomy Trial. , 1992, Stroke.

[31]  L. Wilkins.  North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. , 1991, Stroke.